Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 104

Sort by

Sort Order Select

Journal Articles

The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)

Kenneth I. Ataga, MD, Santosh L. Saraf, MD, Vimal K. Derebail, MD, Claire C. Sharpe, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, MSPH, Laurie DeBonnett, MD, Shirong Zhang, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1018.

https://doi.org/10.1182/blood-2019-124823

Published: 2019

Journal Articles

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Santosh L. Saraf, MD, Vimal K. Derebail, MD, Xu Zhang, PhD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2268.

https://doi.org/10.1182/blood-2019-124737

Published: 2019

Journal Articles

Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis

Andrew Sochacki, MD, Cosmin Adrian Bejan, PhD, Shilin Zhao, PhD, Travis Spaulding, MD, Shannon Stockton, MD, Alexander Silver, Dixon Dorand, MD PhD, Siwei Zhang, PhD, Thomas Stricker, MD PhD, Yaomin Xu, PhD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 2959.

https://doi.org/10.1182/blood-2019-121513

Published: 2019

Journal Articles

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

Boris Tchernychev, PhD, Raghunath Ramanarasimhaiah, MD, Guang Liu, PhD, Katherine Hall, PhD, Regina Margaret Graul, PhD, Jaime Masferrer, PhD

Blood (2019) 134 (Supplement_1): 3554.

https://doi.org/10.1182/blood-2019-127361

Published: 2019

Journal Articles

Lamictal® and Hemophagocytic Lymphohistiocytosis (HLH)

Ibrahim Tora, MD, Logan Rhea, DO, Margaret Holbrook, Physician Assistant, William Ershler, MD, Yemsrach Gami, MD

Blood (2019) 134 (Supplement_1): 4880.

https://doi.org/10.1182/blood-2019-127531

Published: 2019

Journal Articles

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Phani Borra, MD, Cory Edward Mellon, MD

Blood (2019) 134 (Supplement_1): 4905.

https://doi.org/10.1182/blood-2019-128537

Published: 2019

Journal Articles

Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR

Meletios Dimopoulos, David Siegel, Darrell J. White, Ralph Boccia, Karim S. Iskander, Zhao Yang, Amy S. Kimball, Khalid Mezzi, Heinz Ludwig, Ruben Niesvizky

Blood (2019) 133 (2): 147–155.

https://doi.org/10.1182/blood-2018-06-860015

Published: 2019

Includes: Supplemental data

Journal Articles

Real-World Experience of Switching from Deferasirox Dispersible to Film-Coated Tablets: Impact on Adherence to Chelation Therapy, Iron Overload and Renal Function

Simon Cheesman, Raakhee Shah, MPharm, Sara Trompeter, MD, Perla Eleftheriou, FRCPath, MRCP, Bernadette Hylton, RN, Maciej W Garbowski, MDPhD, John Porter, MA MDFRCP FRCPath

Blood (2018) 132 (Supplement 1): 1062.

https://doi.org/10.1182/blood-2018-99-119030

Published: 2018

Journal Articles

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Jeffrey I. Weitz, MD, Gary E. Raskob, PhD, Alex C. Spyropoulos, MD, Alexander T Cohen, MD, Theodore E. Spiro, MD, Yoriko De Sanctis, MS, Jianfeng Xu, PhD, Eunyoung Suh, PhD, Wentao Lu, PhD, Concetta Lipardi, MDPhD, Elliot S. Barnathan, MD

Blood (2018) 132 (Supplement 1): 1236.

https://doi.org/10.1182/blood-2018-99-111911

Published: 2018

Journal Articles

Rapid Decline in Kidney Function in Sickle Cell Disease

Vimal K. Derebail, MD, Emily Jane Ciccone, MD, Qingning Zhou, PhD, Jianwen Cai, PhD, Kenneth I. Ataga

Blood (2018) 132 (Supplement 1): 1084.

https://doi.org/10.1182/blood-2018-99-117057

Published: 2018

Journal Articles

Ruxolitinib Therapy Improves Renal Function in Patients with Primary Myelofibrosis

Paolo Strati, MD, Maen Abdelrahim, Umut Selamet, Valda Page, Sherry A. Pierce, BSN, BA, Srdan Verstovsek, MD PhD, Ala Abudayyeh

Blood (2018) 132 (Supplement 1): 4296.

https://doi.org/10.1182/blood-2018-99-109871

Published: 2018

Journal Articles

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Joseph R. Leventhal, MD PhD, John P. Galvin, MDMS,MPH, James Mathew, PhD, Lorenzo Gallon, MD, Kadiyala Ravindra, MD, Mitchell E. Horwitz, MD, Michael Abecassis, MD, MBA, Suzanne T Ildstad, MD

Blood (2018) 132 (Supplement 1): 202.

https://doi.org/10.1182/blood-2018-99-118832

Published: 2018

Journal Articles

Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function

Yevgeniya Foster, MD, Michael J Grant, MD, Samantha M Thomas, MS, Blake Cameron, MD MBI, Doug Raiff, PharmD, BCPS, Kelly Corbet, B.S., Christopher Ferreri, MD, Mitchell E. Horwitz, MD

Blood (2018) 132 (Supplement 1): 4594.

https://doi.org/10.1182/blood-2018-99-113189

Published: 2018

Journal Articles

Description of the First Cases with ADAMTS13 Mutations in Hungary

Marienn Réti, MD, György Sinkovits, MD, Orsolya Cseprekál, MD PhD, Dorottya Csuka, PhD, Ágnes Szilágyi, PhD, Zita Farkas, MD, Zsolt Klucsik, MD, Attila Szederjesi, MSC, László Wágner, MD Prof, György Reusz, MD Prof, Johanna A. Kremer Hovinga, MD Prof, János Rigó, MD Prof, Tamas Masszi, MD Prof., Zoltan Prohászka, MD Prof

Blood (2018) 132 (Supplement 1): 5003.

https://doi.org/10.1182/blood-2018-99-118327

Published: 2018

Journal Articles

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Reem Alharbi, Mahmoud Aljurf, MD, Raid El Fakih, MD, Mohammad Al Nahedh, PharmD, Majed Huessein, MD, Zubeir Ahmed Nurgat, BSc, MSc, Almohareb Fahad, MD, Naeem A. Chaudhri, MD, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Saud Alhayli, MD, Riad Youniss, Shahrukh Hashmi, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 3358.

https://doi.org/10.1182/blood-2018-99-114667

Published: 2018

Journal Articles

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (RRMM) Based on Prior Treatment History, Renal Function, and Cytogenetic Risk: Subgroup Analyses of Pollux

Philippe Moreau, MDPhD, Albert Oriol, MD, Jonathan L. Kaufman, MD, Heather Sutherland, MD, Marc Lalancette, MD FRCP, Hila Magen, MD, Shinsuke Iida, MD PhD, Jin Seok Kim, MD PhD, Miles Prince, MD FRACP, FRCPA, Tara Cochrane, Lisa O'Rourke, MSN, RN, Kaida Wu, Jordan M. Schecter, Nizar J. Bahlis, MD

Blood (2017) 130 (Supplement 1): 1883.

https://doi.org/10.1182/blood.V130.Suppl_1.1883.1883

Published: 2017

Journal Articles

Urinary Specific Gravity Decreases over Time in Adult Sickle Cell Patients

Vimal K. Derebail, MD, Poulami Maitra, MS, Emily Jane Ciccone, MD, Ashley Thrower, BS, R Rosina Kilgore, MD, Jianwen Cai, PhD, Kenneth I Ataga, MD

Blood (2017) 130 (Supplement 1): 4783.

https://doi.org/10.1182/blood.V130.Suppl_1.4783.4783

Published: 2017

Journal Articles

Longitudinal Evaluation of Renal Function in Multiple Myeloma

Marlies Antlanger, Thomas Reiter, MD, Eleonore Pablik, Christoph Minichsdorfer, Edit Porpaczy, MD, Susanne Rasoul-Rockenschaub, Heinz Gisslinger, Hermine Agis, MD, Maria-Theresa Krauth, MD

Blood (2017) 130 (Supplement 1): 5387.

https://doi.org/10.1182/blood.V130.Suppl_1.5387.5387

Published: 2017

Journal Articles

Analysis of Healthcare Provider Practice Patterns from Individual Patient Cases Entered into an Online Treatment Decision Tool for Chronic Lymphocytic Leukemia (CLL)

Kristen M Rosenthal, PhD, Farrukh T. Awan, MD MS, Steven Coutre, MD, Jeffrey A. Jones, MD MPH, MBA, Jeffrey P. Sharman, MD, Kevin L Obholz, PhD, Andrew D. Zelenetz, MD PhD

Blood (2017) 130 (Supplement 1): 5614.

https://doi.org/10.1182/blood.V130.Suppl_1.5614.5614

Published: 2017

Journal Articles

Management of Renal Dysfunctions in Escort-HU Study

Pablo Bartolucci, MD PhD, Gylna Loko, MD, Corinne Charneau, MD, Jean-Antoine Ribeil, MD, Nathalie Lemonne, MD, Stephan Lobitz, MD, Malika Benkerrou, MD, Frederic Galacteros, MDPhD

Blood (2017) 130 (Supplement 1): 3528.

https://doi.org/10.1182/blood.V130.Suppl_1.3528.3528

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

Lamictal® and Hemophagocytic Lymphohistiocytosis (HLH)

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR

Real-World Experience of Switching from Deferasirox Dispersible to Film-Coated Tablets: Impact on Adherence to Chelation Therapy, Iron Overload and Renal Function

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Rapid Decline in Kidney Function in Sickle Cell Disease

Ruxolitinib Therapy Improves Renal Function in Patients with Primary Myelofibrosis

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function

Description of the First Cases with ADAMTS13 Mutations in Hungary

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (RRMM) Based on Prior Treatment History, Renal Function, and Cytogenetic Risk: Subgroup Analyses of Pollux

Urinary Specific Gravity Decreases over Time in Adult Sickle Cell Patients

Longitudinal Evaluation of Renal Function in Multiple Myeloma

Analysis of Healthcare Provider Practice Patterns from Individual Patient Cases Entered into an Online Treatment Decision Tool for Chronic Lymphocytic Leukemia (CLL)

Management of Renal Dysfunctions in Escort-HU Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only